FF
Possible use cases as posited by Google Ai:
“Based on GBrain's core business in neurotechnology and BrainChip's current technical roadmap, their collaboration likely focuses on the following uses of Akidatechnology:
1. Ultra-Low-Power Seizure & Event Detection
GBrain develops graphene-based neural implants (Phin Array) for monitoring brain activity in patients with epilepsy.
BrainChip
The Akida Use Case: Akida's event-based architecture is designed to remain in an "always-on" state while consuming micro-watts of power.
Benefit: GBrain can use Akida to process neural spikes directly on the implant, identifying the onset of a seizure in real-time without the latency or power drain of transmitting raw data to an external device.
BrainChip +3
2. On-Device Personalization (Learning)
A key differentiator of the Akida processor is its ability to perform on-chip learning.
BrainChip
The Akida Use Case: Every patient's neural signatures are unique.
Benefit: GBrain can leverage Akida to "learn" a specific patient's normal brain patterns versus pathological activity on the fly. This allows the medical implant to adapt its detection algorithms to the individual user without requiring cloud-based retraining.
BrainChip
3. Smart Brain Stimulation (Phin Stim)
GBrain's Phin Stim is a wireless stimulator used to treat motor diseases.
AFR
The Akida Use Case: Akida 2.0 and the newer TENNs (Temporal Event-based Neural Networks) are optimized for processing time-series data like EEG or ECoG.
Benefit: By integrating Akida, the Phin Stim can become a "closed-loop" system. Akida identifies the precise moment stimulation is needed (inference) and triggers the electrode immediately, maximizing therapeutic effect while saving battery life.
BrainChip +3
4. AKD1500 & AKD2500 Integration
BrainChip recently initiated the AKD2500 custom silicon projectin February 2026.
**promotion blocked**.com.au
The Akida Use Case: Enablement partners like GBrain typically get early access to these next-gen platforms via the AI Enablement Package.
Benefit: This provides GBrain with the most advanced 12nm neuromorphic IP to minimize the physical footprint of their implants, making them less invasive for patients